Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isrea Life Sciences appears to be an India-based pharmaceutical company operating from Hyderabad, Telangana, focused on marketed healthcare products rather than an innovative clinical-stage biotech pipeline. Publicly visible evidence indicates it markets prescription medicines and over-the-counter products in India, including allergy and hematinic products such as Monrea LC Tablet and Isoheme Tablet, and marketplace listings also associate it with vaccines, laboratory equipment, and healthcare-related distribution. The company is best characterized as a small commercial pharma marketer/distributor rather than a drug discovery platform company. Available public information is sparse and does not show a disclosed R&D pipeline, proprietary platform, or clinical development programs. The entity also appears to have filed trademarks in India under the name Isrea Life Sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isrea Life Sciences.